BIM
ACHN

BlackRock Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

BlackRock Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.8M Sell
435,720
-2,154
-0.5% -$11.4K ﹤0.01% 2285
2016
Q3 		$3.55M Buy
437,874
+674
+0.2% +$5.73K ﹤0.01% 1728
2016
Q2 		$3.41M Buy
437,200
+33,620
+8% +$288K ﹤0.01% 1710
2016
Q1 		$3.12M Buy
403,580
+8,307
+2% +$60.8K ﹤0.01% 1696
2015
Q4 		$4.26M Buy
395,273
+1,482
+0.4% +$13.5K 0.01% 1494
2015
Q3 		$2.72M Sell
393,791
-5,431
-1% -$44.2K ﹤0.01% 1832
2015
Q2 		$3.54M Buy
399,222
+28,773
+8% +$272K ﹤0.01% 1770
2015
Q1 		$3.65M Buy
370,449
+60,311
+19% +$753K ﹤0.01% 1606
2014
Q4 		$3.8M Sell
310,138
-3,458
-1% -$42.2K 0.01% 1580
2014
Q3 		$3.13M Buy
313,596
+3,321
+1% +$30.8K ﹤0.01% 1684
2014
Q2 		$2.35M Buy
310,275
+40,941
+15% +$163K ﹤0.01% 1955
2014
Q1 		$886K Buy
269,334
+149
+0.1% +$521 ﹤0.01% 2597
2013
Q4 		$893K Sell
269,185
-4,730
-2% -$13.7K ﹤0.01% 2586
2013
Q3 		$827K Buy
273,915
+19,879
+8% +$136K ﹤0.01% 2582
2013
Q2 		$2.08M Buy
+254,036
New +$1.94M ﹤0.01% 1826

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock Investment Management's ACHN Position: Q4 2016 in Review

BlackRock Investment Management reduced its Achillion Pharmaceuticals (ACHN) stake by 0.49% in Q4 2016, selling an estimated $11.4K and leaving 435,720 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

BlackRock Investment Management first reported a position in ACHN in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.26M in Q4 2015. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • BlackRock Investment Management held 435,720 shares of Achillion Pharmaceuticals worth $1.8M as of Q4 2016.
  • BlackRock Investment Management sold 2,154 Achillion Pharmaceuticals shares in Q4 2016, an estimated $11.4K.
  • Achillion Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2285 holding.
  • BlackRock Investment Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Achillion Pharmaceuticals position peaked at $4.26M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.